Skip to content

Drug interactions

Carbamazepine + Enfortumab vedotin

Severity: Minor

Carbamazepine and Enfortumab vedotin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Enfortumab vedotin releases MMAE, a CYP3A4 substrate, and carbamazepine may lower its exposure. Reduced exposure could weaken efficacy, although the effect is predicted rather than well studied.

What this interaction means in plain words

Carbamazepine and Enfortumab vedotin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Carbamazepine belongs to Central Nervous System; Enfortumab vedotin belongs to Oncology.

Evidence level: Low

Why it happens

Carbamazepine induces CYP3A4, which may increase clearance of the released MMAE.

What to do

No dose change is required. Monitor treatment response and consider a non-inducing anticonvulsant if loss of efficacy is suspected.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Carbamazepine and Enfortumab vedotin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Carbamazepine with Enfortumab vedotin?

MediHelp rates the interaction as minor. Carbamazepine and Enfortumab vedotin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Enfortumab vedotin releases MMAE, a CYP3A4 substrate, and carbamazepine may lower its exposure. Reduced exposure could weaken efficacy, although the effect is predicted rather than well studied.

How serious is the interaction between Carbamazepine and Enfortumab vedotin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is required. Monitor treatment response and consider a non-inducing anticonvulsant if loss of efficacy is suspected.

What other medicines interact with Carbamazepine?

MediHelp also lists interactions of Carbamazepine with, for example, Artemether / lumefantrine, Cabotegravir, Delamanid. The full list is on the Carbamazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in